Conference on cancer, stem cell transplant held
Published: 06:05 PM,May 25,2024 | EDITED : 10:05 PM,May 25,2024
MUSCAT: Muscat Family Physicians’ Group in association with HCG Cancer Hospital, Bengaluru & Global Treatment Services organised an International Medical Conference in Muscat on Friday.
Dr Wahid al Kharusi, senior orthopaedic surgeon, chairman of Oman Cancer Society and Dr Khalid al Hashmi, senior consultant and HOD of Haematoma-Oncology, MOD Hospital Al Khoudh, were guests of honour. Dr Natraj K L in his presentation said, “The field of cancer is evolving rapidly, that too the field of blood and blood related cancers are evolving at a rapid pace. The newer therapies like CART (Chimeric Antigen Receptor Based T cell therapies) have become most sought of treatments for relapsed blood cancers, lymphoma and multiple myeloma. The patient who would have had no response and refractory to the available therapies are now achieving deeper responses with these newer therapies. These therapies work best for relapse acute lymphoblastic leukaemia, relapsed B Cell Lymphomas and multiple myeloma patients. These were accessible only in west in the past but now accessible easily in India that too in HCG Bengaluru Hospital which is a specialist cancer hospital. We rapidly adopt technologies to make lives of patients better.” Dr Nithin Teja in his presentation said, “In Musculoskeletal oncology the right treatment the first time is a very important step. Because 97 per cent of the bone and muscle tumours can be cured if the right treatment is done at the first instance. This can be achieved by a thorough assessment by clinical, radiological , pathological modalities and by a multidisciplinary team approach in planning the treatment. With about 15 years of experience in Musculoskeletal Oncology and after managing about 8,000 cases, a team of doctors at HCG Bengaluru is now in a position to treat most of the complex Musculoskeletal tumours.'
Meeting was attended by around 65 leading medical practitioners from both ministry and private health establishments of Oman.
Dr Wahid al Kharusi, senior orthopaedic surgeon, chairman of Oman Cancer Society and Dr Khalid al Hashmi, senior consultant and HOD of Haematoma-Oncology, MOD Hospital Al Khoudh, were guests of honour. Dr Natraj K L in his presentation said, “The field of cancer is evolving rapidly, that too the field of blood and blood related cancers are evolving at a rapid pace. The newer therapies like CART (Chimeric Antigen Receptor Based T cell therapies) have become most sought of treatments for relapsed blood cancers, lymphoma and multiple myeloma. The patient who would have had no response and refractory to the available therapies are now achieving deeper responses with these newer therapies. These therapies work best for relapse acute lymphoblastic leukaemia, relapsed B Cell Lymphomas and multiple myeloma patients. These were accessible only in west in the past but now accessible easily in India that too in HCG Bengaluru Hospital which is a specialist cancer hospital. We rapidly adopt technologies to make lives of patients better.” Dr Nithin Teja in his presentation said, “In Musculoskeletal oncology the right treatment the first time is a very important step. Because 97 per cent of the bone and muscle tumours can be cured if the right treatment is done at the first instance. This can be achieved by a thorough assessment by clinical, radiological , pathological modalities and by a multidisciplinary team approach in planning the treatment. With about 15 years of experience in Musculoskeletal Oncology and after managing about 8,000 cases, a team of doctors at HCG Bengaluru is now in a position to treat most of the complex Musculoskeletal tumours.'
Meeting was attended by around 65 leading medical practitioners from both ministry and private health establishments of Oman.